Home/Filings/4/0001213900-20-023494
4//SEC Filing

Johnson Bankole A. 4

Accession 0001213900-20-023494

CIK 0001513525other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 4:59 PM ET

Size

12.8 KB

Accession

0001213900-20-023494

Insider Transaction Report

Form 4
Period: 2020-08-20
Johnson Bankole A.
Director10% Owner
Transactions
  • Sale

    Common Stock

    2020-08-20$1.21/sh350,000$423,5001,055 total
Holdings
  • Common Stock

    (indirect: By LLC)
    40,463
  • Common Stock

    (indirect: By Trust)
    10,000
  • Common Stock

    (indirect: By Trust)
    22,320
  • Common Stock

    (indirect: By Trust)
    93,000
  • Common Stock

    (indirect: By Trust)
    698,336
  • Common Stock

    (indirect: Efunbowale Johnson)
    4,650
  • Common Stock

    (indirect: Ade Johnson)
    1,395
  • Common Stock

    (indirect: Lina Tiouririne)
    930
Footnotes (4)
  • [F1]The reporting person sold 350,000 shares of the issuer's common stock pursuant to a Stock Purchase Agreement dated as of August 19, 2020 for an aggregate purchase price of $425,000.
  • [F2]Medico-Trans Company, LLC is controlled by Bankole Johnson.
  • [F3]Dr. Johnson is the trustee of each of these trusts.
  • [F4]Dr. Johnson has a voting proxy on this person's behalf that entitles him to vote these shares.

Documents

1 file

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1
  • filerCIK 0001718158

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 4:59 PM ET
Size
12.8 KB